Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
187.28
166.32
163.36
154.07
168.18
146.55
161.21
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
187.28
166.32
163.36
154.07
168.18
146.55
161.21
Raw Material Cost
73.73
47.68
57.20
60.97
53.93
50.16
57.10
Purchase of Finished goods
16.45
25.03
21.72
15.83
14.75
18.61
21.86
(Increase) / Decrease In Stocks
-1.10
3.25
-2.18
-7.42
11.48
-0.13
-6.66
Employee Cost
32.46
30.62
30.36
31.76
27.62
27.98
27.84
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
0.01
0.00
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
40.90
36.15
30.82
29.12
33.69
26.27
32.71
Total Expenditure (Excl Depreciation)
162.43
142.73
137.93
130.26
141.46
122.89
132.84
Operating Profit (PBDIT) excl Other Income
24.85
23.59
25.43
23.81
26.72
23.66
28.37
Other Income
-4.20
15.15
7.23
15.27
-6.88
8.97
9.98
Operating Profit (PBDIT)
20.65
38.74
32.66
39.08
19.84
32.63
38.35
Interest
0.27
0.30
0.23
0.21
0.37
0.73
0.35
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
20.38
38.44
32.43
38.87
19.47
31.90
38.00
Depreciation
3.68
3.72
3.62
3.48
3.23
3.22
3.22
Profit Before Tax
16.70
34.72
28.81
35.39
16.25
28.68
34.78
Tax
5.07
6.12
8.83
7.71
4.67
7.91
8.45
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
11.63
28.60
19.98
27.68
11.58
20.77
26.33
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
11.63
28.60
19.98
27.68
11.58
20.77
26.33
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
11.63
28.60
19.98
27.68
11.58
20.77
26.33
Equity Capital
20.03
20.03
20.03
20.03
20.03
20.03
20.03
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
5.81
14.28
9.98
13.82
5.78
10.37
13.15
Diluted Earnings per share
5.81
14.28
9.98
13.82
5.78
10.37
13.15
Operating Profit Margin (Excl OI)
13.27%
14.18%
15.57%
15.45%
15.89%
16.14%
17.6%
Gross Profit Margin
10.88%
23.11%
19.85%
25.23%
11.58%
21.77%
23.57%
PAT Margin
6.21%
17.2%
12.23%
17.97%
6.89%
14.17%
16.33%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 11.36% vs 18.03% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 0.43% vs -37.74% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -7.00% vs 45.38% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -27.03% vs -26.00% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
Compare Quarterly Results Of Lincoln Pharma. With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
187.28
160.93
26.35
16.37%
Other Operating Income
0.00
0.00
0.00
Total Operating income
187.28
160.93
26.35
16.37%
Raw Material Cost
73.73
118.91
-45.18
-38.00%
Purchase of Finished goods
16.45
0.00
16.45
(Increase) / Decrease In Stocks
-1.10
-7.35
6.25
85.03%
Employee Cost
32.46
8.15
24.31
298.28%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
3.72
-3.73
-100.27%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
40.90
11.16
29.74
266.49%
Total Expenditure (Excl Depreciation)
162.43
134.59
27.84
20.69%
Operating Profit (PBDIT) excl Other Income
24.85
26.34
-1.49
-5.66%
Other Income
-4.20
0.00
-4.20
Operating Profit (PBDIT)
20.65
26.34
-5.69
-21.60%
Interest
0.27
10.55
-10.28
-97.44%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
20.38
15.79
4.59
29.07%
Depreciation
3.68
1.78
1.90
106.74%
Profit Before Tax
16.70
14.00
2.70
19.29%
Tax
5.07
3.52
1.55
44.03%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
11.63
10.48
1.15
10.97%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
11.63
10.48
1.15
10.97%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
11.63
10.48
1.15
10.97%
Equity Capital
20.03
4.72
15.31
324.36%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
5.81
22.20
-16.39
-73.83%
Diluted Earnings per share
5.81
22.19
-16.38
-73.82%
Operating Profit Margin (Excl OI)
13.27%
16.47%
0.00
-3.20%
Gross Profit Margin
10.88%
9.87%
0.00
1.01%
PAT Margin
6.21%
6.55%
0.00
-0.34%
Public Share Holdings (%)
0.00%
51.07%
-51.07
-51.07%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 187.28 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 12.60% vs 1.81% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 11.36% vs 18.03% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 11.63 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is -59.34% vs 43.14% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 0.43% vs -37.74% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 24.85 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 5.34% vs -7.24% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -7.00% vs 45.38% in Mar 2025
Quarterly - Interest
Interest 0.27 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is -10.00% vs 30.43% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -27.03% vs -26.00% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.27%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
